Skip to main content
TipRanks
Go Ultimate75% OFF

Compare MannKind (NNFN) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:NNFNMannKindCHF 3.36CHF 1.10B-17.13-1.00%Strong BuyUnlock the CH:NNFN analyst price target with TipRanks PremiumCH:NNFNUnlock the CH:NNFN top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.78$792.52M-12.2821.92%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumCH:NNFN vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$18.30$1.30B7.22-16.70%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumCH:NNFN vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$4.48$988.39M-7.306.67%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumCH:NNFN vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$16.80$3.07B-416.12131.40%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumCH:NNFN vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:NNFNMannKind3.36-0.03-1.00%
LXRXLexicon Pharmaceuticals1.780.3322.76%
INVAInnoviva18.30-2.97-13.96%
SVRASavara4.48-0.12-2.61%
XERSXeris Pharmaceuticals16.809.71136.95%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts